News Conference News ACC 2026 Financial Support After Hospital Discharge Boosts HFrEF Outcomes: FUND-HF L.A. McKeown April 08, 2026
News Conference News ACC 2026 DIG-RHD: Digoxin Effective in Rheumatic Heart Disease Michael O'Riordan April 06, 2026
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for March 2026 Caitlin E. Cox April 01, 2026
News Conference News ACC 2026 SMART-DECISION: Stopping Beta-blockers Post-MI Safe in Stable Patients Michael O'Riordan March 30, 2026
News Conference News ACC 2026 SPIRIT-HF: Spironolactone’s Benefit Still Uncertain in HF With Preserved, Mildly Reduced EF Todd Neale March 29, 2026
News Conference News ACC 2026 Mechanical Circulatory Support Doesn’t Reduce Infarct Size in STEMI Michael O'Riordan March 28, 2026
News Conference News CRT 2026 TAVR-MET: Early Signs Point to Less Postprocedural Valve Dysfunction With Tirzepatide L.A. McKeown March 19, 2026
News Conference News THT 2026 Baroreflex Activation for Advanced HF Yields Positive Results: Postmarketing Data Todd Neale March 05, 2026
News Conference News THT 2026 AI-Enabled Virtual HF Care May Help Boost GDMT, Stabilize Weight Todd Neale March 03, 2026
News Features Holding Out Hope for HF Shunts, Even After an FDA Panel’s Doubts Michael O'Riordan February 24, 2026
News Daily News Oral GLP-1s Provide Benefit in HF Patients: SOUL Subanalysis L.A. McKeown February 06, 2026
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for January 2026 Caitlin E. Cox February 02, 2026
News Daily News Even With Optimized GDMT, HFrEF Prognosis Remains Dire Michael O'Riordan January 30, 2026
News Daily News Telemedicine May Adversely Impact Care Quality for HF Patients Caitlin E. Cox January 26, 2026
News Daily News Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure Michael O'Riordan December 30, 2025